MALI: THE VITAL CHALLENGE OF ANTI-HIV TREATMENT FOR CHILDREN
September 8, 2016
Each year, an estimated 1.4 million women with HIV become pregnant worldwide. In the absence of antiretroviral (ARV) treatment, these women have a probability of 15% to 45% of transmitting HIV to their babies during pregnancy, at delivery or through breastfeeding. However, the risk shrinks to less than 1% if the precious ARV molecules are administered to them and their infants at all stages where infection can take place.
In Mali, one of the priority axes of advocacy by Coalition PLUS focuses precisely on reinforcing the national plan for the elimination of HIV transmission from mother to child. In recent months, our advocate, Fatoumata Konaté, targeted the shortages of pediatric anti-retroviral treatments along with the weaknesses of the distribution network for these essential medicines, shortcomings that threaten the lives of thousands of Malian children living with HIV.
This problem affects Africa as a whole. According to UNAIDS, of the more than 2.6 million children under the age of 15 years currently living with HIV worldwide, 90 % live on that continent. However, barely 18 % of African children with HIV have access to the treatments they need to survive. And half of all children born with HIV in Africa die before their second birthday for lack of appropriate medical coverage.
The African members of Coalition PLUS take to the field each day to tackle this sad reality and change it. This fundamental work is possible thanks to your precious financial support. Thank you!
Access the Coalition PLUS 2015 activity report at coalitionplus.org.